Casey D. Johnson

4.6k total citations · 3 hit papers
35 papers, 3.8k citations indexed

About

Casey D. Johnson is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Casey D. Johnson has authored 35 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 15 papers in Molecular Biology and 13 papers in Hepatology. Recurrent topics in Casey D. Johnson's work include Liver Disease Diagnosis and Treatment (21 papers), Inflammasome and immune disorders (9 papers) and Liver Disease and Transplantation (9 papers). Casey D. Johnson is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Inflammasome and immune disorders (9 papers) and Liver Disease and Transplantation (9 papers). Casey D. Johnson collaborates with scholars based in United States, Germany and Australia. Casey D. Johnson's co-authors include Ariel E. Feldstein, Alexander Wree, Akiko Eguchi, Hal M. Hoffman, Matthew D. McGeough, Carla A. Peña, Ali Canbay, Bettina G. Papouchado, Davide Povero and Carolina Jiménez Calvente and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Casey D. Johnson

34 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice

2017 863 citations Auvro R. Mridha, Alexander Wree et al. Journal of Hepatology profile →
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice

2013 779 citations Alexander Wree, Akiko Eguchi et al. Hepatology profile →
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis

2020 405 citations Susanne Gaul, Aleksandra Leszczynska et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Casey D. Johnson United States	21	2.0k	2.0k	907	633	434	35	3.8k
Christian Liedtke Germany	40	2.0k 1.0×	1.5k 0.8×	1.2k 1.3×	632 1.0×	538 1.2×	108	4.6k
Honglei Weng Germany	32	1.2k 0.6×	1.1k 0.6×	1.2k 1.3×	468 0.7×	479 1.1×	79	3.2k
Pau Sancho‐Bru Spain	40	1.3k 0.6×	2.4k 1.2×	2.2k 2.4×	430 0.7×	991 2.3×	85	4.7k
Kouichi Miura Japan	25	1.3k 0.6×	2.2k 1.1×	1.3k 1.4×	452 0.7×	535 1.2×	78	3.7k
Yan‐Xiao Ji China	29	1.4k 0.7×	1.5k 0.7×	445 0.5×	273 0.4×	225 0.5×	50	3.1k
Erawan Borkham‐Kamphorst Germany	29	924 0.5×	1.1k 0.6×	1.2k 1.3×	383 0.6×	475 1.1×	51	2.8k
Satoshi Shimizu Japan	30	1.9k 0.9×	1.2k 0.6×	769 0.8×	467 0.7×	572 1.3×	135	4.3k
Haixia Cao China	30	1.7k 0.8×	1.1k 0.6×	266 0.3×	268 0.4×	367 0.8×	101	3.4k
Tomonori Aoyama Japan	20	773 0.4×	1.6k 0.8×	1.1k 1.2×	617 1.0×	412 0.9×	34	2.9k
Hyon‐Seung Yi South Korea	31	1.2k 0.6×	867 0.4×	348 0.4×	612 1.0×	288 0.7×	99	3.0k

Countries citing papers authored by Casey D. Johnson

Since Specialization

Citations

This map shows the geographic impact of Casey D. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Casey D. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Casey D. Johnson more than expected).

Fields of papers citing papers by Casey D. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Casey D. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Casey D. Johnson. The network helps show where Casey D. Johnson may publish in the future.

Co-authorship network of co-authors of Casey D. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Casey D. Johnson. A scholar is included among the top collaborators of Casey D. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Casey D. Johnson. Casey D. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takeda, Katsuyuki, Anthony Joetham, Miloš Lazić, et al.. (2023). JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders. Scientific Reports. 13(1). 13524–13524. 14 indexed citations

Liang, Nuanyi, Marie Hennebelle, Susanne Gaul, et al.. (2021). Feeding mice a diet high in oxidized linoleic acid metabolites does not alter liver oxylipin concentrations. Prostaglandins Leukotrienes and Essential Fatty Acids. 172. 102316–102316. 3 indexed citations

Name, Michelle Van, Mary Savoye, Ariel E. Feldstein, et al.. (2020). A Low ω-6 to ω-3 PUFA Ratio (n–6:n–3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth. Journal of Nutrition. 150(9). 2314–2321. 57 indexed citations

Gaul, Susanne, Aleksandra Leszczynska, Fernando Alegre, et al.. (2020). Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. Journal of Hepatology. 74(1). 156–167. 405 indexed citations breakdown →

Gaul, Susanne, Lukas Geisler, Matthew D. McGeough, et al.. (2020). ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model. JCI Insight. 5(2). 58 indexed citations

Calvente, Carolina Jiménez, et al.. (2019). MicroRNA 223 3p Negatively Regulates the NLRP3 Inflammasome in Acute and Chronic Liver Injury. Molecular Therapy. 28(2). 653–663. 85 indexed citations

Calvente, Carolina Jiménez, Masahiko Tameda, Casey D. Johnson, et al.. (2019). Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. Journal of Clinical Investigation. 129(10). 4091–4109. 199 indexed citations

Maricic, Igor, Idania Marrero, Akiko Eguchi, et al.. (2018). Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis. The Journal of Immunology. 201(10). 3017–3035. 78 indexed citations

Eguchi, Akiko, Yukinori Koyama, Alexander Wree, et al.. (2018). Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligation. Journal of Molecular Medicine. 96(6). 575–583. 21 indexed citations

10.

Alkhouri, Naim, Casey D. Johnson, Leon A. Adams, et al.. (2018). Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis. PLoS ONE. 13(8). e0202226–e0202226. 15 indexed citations

11.

Ramsden, Christopher E., Marie Hennebelle, Susanne Schuster, et al.. (2018). Effects of diets enriched in linoleic acid and its peroxidation products on brain fatty acids, oxylipins, and aldehydes in mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1863(10). 1206–1213. 32 indexed citations

12.

McGeough, Matthew D., Alexander Wree, María Eugenia Inzaugarat, et al.. (2017). TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies. Journal of Clinical Investigation. 127(12). 4488–4497. 132 indexed citations

13.

Mridha, Auvro R., Alexander Wree, Avril A. B. Robertson, et al.. (2017). NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Journal of Hepatology. 66(5). 1037–1046. 863 indexed citations breakdown →

14.

Johnson, Casey D., Alexander Wree, Davide Povero, et al.. (2016). Hepatic Stellate Cell Specific NLRP3 Inflammasome Activation Results in Spontaneous Fibrosis. RWTH Publications (RWTH Aachen). 1 indexed citations

15.

Eguchi, Akiko, et al.. (2015). Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis. Journal of Hepatology. 64(3). 699–707. 41 indexed citations

16.

Povero, Davide, Nadia Panera, Akiko Eguchi, et al.. (2015). Lipid-Induced Hepatocyte-Derived Extracellular Vesicles Regulate Hepatic Stellate Cells via MicroRNA Targeting Peroxisome Proliferator-Activated Receptor-γ. Cellular and Molecular Gastroenterology and Hepatology. 1(6). 646–663.e4. 190 indexed citations

17.

Wree, Alexander, Casey D. Johnson, Joan Font-Burgada, et al.. (2015). Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation. Cell Death and Differentiation. 22(12). 1985–1994. 22 indexed citations

18.

Lazić, Miloš, Akiko Eguchi, Michael Berk, et al.. (2014). Differential regulation of inflammation and apoptosis in Fas-resistant hepatocyte-specific Bid-deficient mice. Journal of Hepatology. 61(1). 107–115. 12 indexed citations

19.

Johnson, Casey D. & Shusen Ding. (2013). Integral Estimates for the Potential Operator on Differential Forms. Hindawi Journal of Chemistry (Hindawi). 2013. 1–6. 2 indexed citations

20.

Wree, Alexander, Akiko Eguchi, Matthew D. McGeough, et al.. (2013). NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology. 59(3). 898–910. 779 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact